Inventor · disambiguated record
Heidi Lopez De Diego
Also filed as: LOPEZ DE DIEGO HEIDI
16 granted patents·10 pending applications·109 citations·filing 2002–2022
93Inventor score
Files withLUNDBECK & CO AS H9H LUNDBECK AS8BANG-ANDERSEN BENNY3LOPEZ DE DIEGO HEIDI2TREPPENDAHL SVEND2
Top patents by PatentIndex Score
26 records- 0194US8722684B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentBANG-ANDERSEN BENNY·Filed 2007·Granted May 13, 2014·31 cites·8 claims
- 0290US9861630B11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2017·Granted Jan 9, 2018·5 cites·16 claims
- 0386US8299095B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereofBANG-ANDERSEN BENNY·Filed 2007·Granted Oct 30, 2012·8 cites·18 claims
- 0485US8076342B2Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of sameLOPEZ DE DIEGO HEIDI·Filed 2010·Granted Dec 13, 2011·11 cites·10 claims
- 0584US9475748B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2014·Granted Oct 25, 2016·4 cites·14 claims
- 0684US8940746B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineTREPPENDAHL SVEND·Filed 2010·Granted Jan 27, 2015·7 cites·12 claims
- 0784US7767683B2Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicamentLUNDBECK & CO AS H·Filed 2004·Granted Aug 3, 2010·18 cites·12 claims
- 0883US2023021520A11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 0982US9315459B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineLUNDBECK & CO AS H·Filed 2014·Granted Apr 19, 2016·4 cites·17 claims
- 1080US8530495B2Nalmefene hydrochloride dihydrateLOPEZ DE DIEGO HEIDI·Filed 2009·Granted Sep 10, 2013·4 cites·15 claims
- 1180US6844352B21′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine] hydrohalogenidesLUNDBECK & CO AS H·Filed 2002·Granted Jan 18, 2005·16 cites·4 claims
- 1273US11458134B21-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
- 1370US8754217B2Nalmefene hydrochloride dihydrateLUNDBECK & CO AS H·Filed 2013·Granted Jun 17, 2014·1 cites·28 claims
- 1468US2018333408A11-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairmentH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1565US8450324B2Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazineBANG-ANDERSEN BENNY·Filed 2009·Granted May 28, 2013·0 cites·8 claims
- 1660US10034876B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineH LUNDBECK AS·Filed 2016·Granted Jul 31, 2018·0 cites·10 claims
- 1759US12152029B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2022·Granted Nov 26, 2024·0 cites·25 claims
- 1859US2016083359A11-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENTLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1956US2013190352A1Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic painLUNDBECK & CO AS H·Filed 2012·Application pending·0 cites
- 2052US2017037006A1Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineH LUNDBECK AS·Filed 2016·Application pending·0 cites
- 2152US2021147367A1Crystalline forms of a magl inhibitorLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2020·Application pending·0 cites
- 2249US2005171135A11'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenidesLUNDBECK & CO AS H·Filed 2004·Application pending·0 cites
- 2346US2012165325A1Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideTREPPENDAHL SVEND·Filed 2012·Application pending·0 cites
- 2444US2010286138A1Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideLUNDBECK & CO AS H·Filed 2010·Application pending·0 cites
- 2543US2008269248A1Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-DimethylpiperazineLUNDBECK & CO AS H·Filed 2006·Application pending·0 cites
- 2642US8729065B2Crystalline forms of a pharmaceutical compoundROCK MICHAEL HAROLD·Filed 2011·Granted May 20, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →